Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Immunological Aspects of Malignant Gliomas
NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Dendritic cell vaccination in melanoma patients: From promising results to future perspectives
Anti-tumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro.
Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
Thermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma
Comparison of biological effects of modulated electro-hyperthermia and conventional heat treatment in human lymphoma U937 cells
Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies
Electro-hyperthermia up-regulates tumour suppressor Septin 4 to induce apoptotic cell death in hepatocellular carcinoma
Dendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.
Safety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).
Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
5-year follow up for 72 metastatic melanoma patients treated with eltrapuldencel-T (CLBS20) vaccine.
Association of increased survival in glioblastoma patients treated with dendritic cell vaccinations and temozolomide with increased activity of NK cells and ABCC3 expression.
Recent advances in immuno-oncology and its application to urological cancers
A feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.
Dendritic cell vaccine transduced with ubiquitin-mesothelin fusion gene for pancreatic cancer.
Immune effects by selective heating of membrane rafts of cancer-cells.